Eye drops could replace needles for wet AMD?
Disease control
Ongoing
This early-stage trial tests whether NT-101 eye drops can safely control wet age-related macular degeneration (AMD), a leading cause of vision loss. About 30 adults aged 50 and older with active wet AMD will use the drops for up to 8 weeks. The main goal is to check safety, but r…
Phase: PHASE1, PHASE2 • Sponsor: NexThera Co., Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC